Lawsuits against Ozempic and other GLP-1 drugs urge consumer caution episode artwork

EPISODE · Jan 28, 2026 · 15 MIN

Lawsuits against Ozempic and other GLP-1 drugs urge consumer caution

from The Excerpt

GLP-1 drugs like Ozempic and Wegovy are everywhere — but thousands of users now allege the medications caused severe, life-altering injuries including everything from stomach paralysis and colon ruptures to sudden blindness. Drugmakers deny the allegations and say the medications are safe when used as directed. USA TODAY investigative data reporter Austin Fast explains what patients are alleging in court, how widespread GLP-1 use has become and how drug companies like Novo Nordisk and Eli Lilly are responding. Let us know what you think of this episode by sending an email to [email protected]. Episode transcript available here. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Episode metadata supplied by the publisher feed · Published Jan 28, 2026

Embed this episode

Ready to play

Lawsuits against Ozempic and other GLP-1 drugs urge consumer caution

0:00 15:14

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Excerpt?

This episode is 15 minutes long.

When was this The Excerpt episode published?

This episode was published on January 28, 2026.

Can I download this The Excerpt episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!